A detailed history of Buckhead Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Buckhead Capital Management LLC holds 1,850 shares of LLY stock, worth $1.64 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
1,850
Previous 1,920 3.65%
Holding current value
$1.64 Million
Previous $1.49 Million 12.12%
% of portfolio
0.58%
Previous 0.53%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $50,740 - $63,632
-70 Reduced 3.65%
1,850 $1.67 Million
Q1 2024

May 03, 2024

SELL
$592.2 - $792.28 $108,964 - $145,779
-184 Reduced 8.75%
1,920 $1.49 Million
Q4 2023

Feb 05, 2024

BUY
$525.19 - $619.13 $7,877 - $9,286
15 Added 0.72%
2,104 $1.23 Million
Q3 2023

Nov 09, 2023

SELL
$434.7 - $599.3 $26,516 - $36,557
-61 Reduced 2.84%
2,089 $1.12 Million
Q2 2023

Aug 10, 2023

SELL
$350.74 - $468.98 $8,067 - $10,786
-23 Reduced 1.06%
2,150 $1.01 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $111,205 - $130,605
-358 Reduced 14.14%
2,173 $746,000
Q4 2022

Feb 08, 2023

SELL
$321.55 - $374.67 $133,443 - $155,488
-415 Reduced 14.09%
2,531 $925,000
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $14,824 - $16,893
-50 Reduced 1.67%
2,946 $953,000
Q2 2022

Aug 05, 2022

BUY
$278.73 - $327.27 $1,114 - $1,309
4 Added 0.13%
2,996 $971,000
Q3 2021

Nov 05, 2021

SELL
$221.6 - $272.71 $6,648 - $8,181
-30 Reduced 0.99%
2,992 $691,000
Q2 2021

Aug 06, 2021

SELL
$180.55 - $233.54 $9,027 - $11,677
-50 Reduced 1.63%
3,022 $694,000
Q1 2021

Apr 27, 2021

BUY
$164.32 - $212.72 $12,324 - $15,954
75 Added 2.5%
3,072 $574,000
Q4 2020

Feb 09, 2021

BUY
$130.46 - $172.63 $37,311 - $49,372
286 Added 10.55%
2,997 $506,000
Q3 2020

Nov 12, 2020

BUY
$146.22 - $169.13 $38,748 - $44,819
265 Added 10.83%
2,711 $401,000
Q2 2020

Aug 03, 2020

BUY
$136.42 - $164.18 $333,683 - $401,584
2,446 New
2,446 $402,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Buckhead Capital Management LLC Portfolio

Follow Buckhead Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buckhead Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buckhead Capital Management LLC with notifications on news.